{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T03:11:04Z","timestamp":1725851464325},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.suc.2007.03.004","type":"journal-article","created":{"date-parts":[[2007,6,8]],"date-time":"2007-06-08T16:54:26Z","timestamp":1181321666000},"page":"727-741","source":"Crossref","is-referenced-by-count":10,"title":["Novel and Future Medical Management of Inflammatory Bowel Disease"],"prefix":"10.1016","volume":"87","author":[{"given":"Robert W.","family":"Summers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.suc.2007.03.004_bib1","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","article-title":"A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group","volume":"337","author":"Targan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.suc.2007.03.004_bib2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0016-5085(99)70332-X","article-title":"Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease","volume":"117","author":"Rutgeerts","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.suc.2007.03.004_bib3","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.suc.2007.03.004_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2005.11.030","article-title":"Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial","volume":"130","author":"Hanauer","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.suc.2007.03.004_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/gut.2006.106781","article-title":"Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial","author":"Sandborn","year":"2007","journal-title":"Gut"},{"issue":"Suppl VII","key":"10.1016\/j.suc.2007.03.004_bib6","first-page":"A82","article-title":"Certolizumab pegol, a humanized anti-TNF pegylated FAb' fragment, is safe and effective in the maintenance of response and remission following induction in active Crohn's disease; a Phase III study (Precise)","volume":"54","author":"Schreiber","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.suc.2007.03.004_bib7","unstructured":"Loftus EV Jr. Biologic therapy in Crohn's disease: review of the evidence. Rev Gastroenterol Disord 2007;(Suppl 1):S3\u201312."},{"key":"10.1016\/j.suc.2007.03.004_bib8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1053\/j.gastro.2005.06.064","article-title":"A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for the treatment of Crohn's disease","volume":"129","author":"Schreiber","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.suc.2007.03.004_bib9","article-title":"Certolizumab pegol administered subcutaneously is effective and well-tolerated in patients with active Crohn's disease: results from a 26-week, placebo-controlled Phase III study (Precise I)","volume":"130","author":"Sandborn","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.suc.2007.03.004_bib10","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1056\/NEJMoa043335","article-title":"Natalizumab induction and maintenance therapy for Crohn's disease","volume":"353","author":"Sanborn","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.suc.2007.03.004_bib11","first-page":"A62","article-title":"A humanized anti-CD3 monoclonal antibody, visilizumab, for treatment of severe steroid-refractory ulcerative colitis: preliminary results of Phase I study","volume":"134","author":"Plevy","year":"2003","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.suc.2007.03.004_bib12","first-page":"A75","article-title":"A humanized anti-CD3 monoclonal antibody, visilizumab, for treatment of severe steroid-refractory ulcerative colitis: results of a Phase I study","volume":"126","author":"Plevy","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.suc.2007.03.004_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1348-0421.2002.tb02686.x","article-title":"Il-10 producing CD14 low monocytes by commensal bacteria","volume":"46","author":"Haller","year":"2002","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.suc.2007.03.004_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1053\/gast.2000.9370","article-title":"Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial","volume":"119","author":"Gionchetti","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.suc.2007.03.004_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gut.53.1.108","article-title":"Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis","volume":"53","author":"Mimura","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.suc.2007.03.004_bib16","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1136\/gut.34.11.1547","article-title":"Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and South Asians in Leicestershire","volume":"34","author":"Probert","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.suc.2007.03.004_bib17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","article-title":"A frameshift in NOD2 associated with susceptibility to Crohn's disease","volume":"411","author":"Ogua","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.suc.2007.03.004_bib18","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1096\/fj.99-0885hyp","article-title":"Does the failure to acquire helminthic parasites predispose to Crohn's disease","volume":"14","author":"Elliott","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.suc.2007.03.004_bib19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nri1183","article-title":"Immune regulation by helminth parasites: cellular and molecular mechanisms","volume":"3","author":"Maizels","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.suc.2007.03.004_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gut.53.1.7","article-title":"Helminths and harmony: mounting evidence suggests that helminths help regulate mucosal inflammation","volume":"53","author":"Weinstock","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.suc.2007.03.004_bib21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00281-005-0209-3","article-title":"Role of helminths in regulating mucosal inflammation","volume":"27","author":"Weinstock","year":"2005","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.suc.2007.03.004_bib22","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/75015","article-title":"Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy","volume":"6","author":"Fox","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.suc.2007.03.004_bib23","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1128\/IAI.70.11.5931-5937.2002","article-title":"Intestinal nematode infection ameliorates experimental colitis in mice","volume":"70","author":"Khan","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.suc.2007.03.004_bib24","first-page":"G385","article-title":"Exposure to schistosome eggs protects mice from TNBS colitis","volume":"284","author":"Elliott","year":"2003","journal-title":"Am J Physiol"},{"key":"10.1016\/j.suc.2007.03.004_bib25","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1002\/eji.200324833","article-title":"Heligomonsomoides polygyrus inhibits established colitis in IL-10-deficient mice","volume":"34","author":"Elliott","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.suc.2007.03.004_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/gut.53.1.99","article-title":"Concurrent infection with Schistosoma mansoni attenuates inflammation-induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats","volume":"53","author":"Moreels","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.suc.2007.03.004_bib27","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1111\/j.1572-0241.2003.07660.x","article-title":"Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease","volume":"98","author":"Summers","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.suc.2007.03.004_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/gut.2004.041749","article-title":"Trichuris suis therapy in Crohn's disease","volume":"54","author":"Summers","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.suc.2007.03.004_bib29","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2005.01.005","article-title":"Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial","volume":"128","author":"Summers","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.suc.2007.03.004_bib30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/gut.2005.079129","article-title":"A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors","volume":"55","author":"Croese","year":"2006","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.suc.2007.03.004_bib31","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00004836-200607000-00005","article-title":"Pilot feasibility studies of leukacytopheresis with the Adacolumn Apheresis system in patients with active ulcerative colitis or Crohn's disease","volume":"40","author":"Sands","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.suc.2007.03.004_bib32","first-page":"510","article-title":"Developments in the apheresis procedure for the treatment of inflammatory bowel disease","author":"Pineda","year":"2006","journal-title":"Inflam Bowel Dis"},{"issue":"Suppl 1","key":"10.1016\/j.suc.2007.03.004_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/01.MIB.0000195387.26892.22","article-title":"Preliminary data on the use of apheresis in inflammatory bowel disease","author":"Sandborn","year":"2006","journal-title":"Inflam Bowel Dis"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610907000254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610907000254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T20:27:23Z","timestamp":1546806443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610907000254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0039610907000254"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2007.03.004","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}